Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, et al. Differences in long-term disease activity and treatment of adult patients with childhood-and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2009;61(1):13–20.
Article PubMed PubMed Central Google Scholar
Fung KFK, Chan EY-h, Ma AL-t, Yeung W-l, Lai W-m, Kan EY-l. Vertical gaze palsy and intraoral numbness in a patient with neuro-psychiatric systemic lupus erythematosus: a case report and literature review. Lupus. 2020;29(13):1811–4.
Chan EY-H, Leung KF, Soo ET, Ma AL. A Chinese boy with lupus anticoagulant-hypoprothrombinemia syndrome: a case report and review of the literature. J Pediatr Hematol Oncol. 2021;43(3):e445–e7.
Yap DY, Tang CS, Ma MK, Lam MF, Chan TM. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant. 2012;27(8):3248–54.
Chan EYH, Yap DYH, Wong WHS, Ho TW, Tong PC, Lai WM, et al. Demographics and long-term outcomes of children with end-stage kidney disease: a 20-year territory-wide study. Nephrology (Carlton). 2022;27(2):171–80.
Article CAS PubMed Google Scholar
Oni L, Wright RD, Marks S, Beresford MW, Tullus K. Kidney outcomes for children with lupus nephritis. Pediatr Nephrol. 2021;36(6):1377–85.
Wenderfer SE, Chang JC, Davies AG, Luna IY, Scobell R, Sears C, et al. Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis: Development and Validation of Computable Phenotypes. Clin J Am Soc Nephrol. 2022;17(1):65–74.
Article CAS PubMed PubMed Central Google Scholar
Weening JJ, D’agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521–30.
Markowitz G, D’agati V. The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int. 2007;71(6):491–5.
Article CAS PubMed Google Scholar
Chan EY-h, Yap DY-h, Wong W-t, Wong WH-s, Wong S-w, Lin KY-k, et al. Long-term outcomes of children and adolescents with biopsy-proven childhood-onset lupus nephritis. Kidney Int Rep. 2023;8(1):141–50.
Kwon Y-C, Chun S, Kim K, Mak A. Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond. Cells. 2019;8(10):1180.
Article CAS PubMed PubMed Central Google Scholar
Pineles D, Valente A, Warren B, Peterson M, Lehman T, Moorthy L. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus. 2011;20(11):1187–92.
Article CAS PubMed Google Scholar
Watson L, Beresford M, Maynes C, Pilkington C, Marks S, Glackin Y, et al. The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE. Lupus. 2015;24(1):10–7.
Article CAS PubMed Google Scholar
Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti–double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1999;42(2):328–37.
Article CAS PubMed Google Scholar
Patel M, Clarke AM, Bruce IN, Symmons DP. The prevalence and incidence of biopsy-proven lupus nephritis in the UK: evidence of an ethnic gradient. Arthritis Rheum. 2006;54(9):2963–9.
De Mutiis C, Wenderfer SE, Orjuela A, Bagga A, Basu B, Sar T, et al. Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis. Rheumatology (Oxford). 2021.
Groot N, Shaikhani D, Teng Y, de Leeuw K, Bijl M, Dolhain R, et al. Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2019;71(2):290–301.
Demir S, Gülhan B, Özen S, Çeleğen K, Batu ED, Taş N, et al. Long-term renal survival of paediatric patients with lupus nephritis. Nephrol Dial Transplant. 2021.
Qiu S, Zhang H, Yu S, Yang Q, Zhang G, Yang H, et al. Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis. Pediatr Nephrol. 2022;37(2):367–76.
Wong S-N, Tse K-C, Lee T-L, Lee K-W, Chim S, Lee K-P, et al. Lupus nephritis in Chinese children–a territory-wide cohort study in Hong Kong. Pediatr Nephrol. 2006;21(8):1104–12.
Vachvanichsanong P, Dissaneewate P, McNeil E. Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre. Nephrol Dial Transplant. 2009;24(9):2729–34.
Hari P, Bagga A, Mahajan P, Dinda A. Outcome of lupus nephritis in Indian children. Lupus. 2009;18(4):348–54.
Article CAS PubMed Google Scholar
Pereira T, Abitbol CL, Seeherunvong W, Katsoufis C, Chandar J, Freundlich M, et al. Three decades of progress in treating childhood-onset lupus nephritis. Clin J Am Soc Nephrol. 2011;6(9):2192–9.
Article CAS PubMed PubMed Central Google Scholar
Taheri S, Beiraghdar F. Lupus nephritis in Iranian children: a review of 60 patients. Ren Fail. 2011;33(5):499–505.
Srivastava P, Abujam B, Misra R, Lawrence A, Agarwal V, Aggarwal A. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years. Lupus. 2016;25(5):547–57.
Article CAS PubMed Google Scholar
Suhlrie A, Hennies I, Gellermann J, Büscher A, Hoyer P, Waldegger S, et al. Twelve-month outcome in juvenile proliferative lupus nephritis: results of the German registry study. Pediatr Nephrol. 2020;35(7):1235–46.
Chan EY-h, Liu M-s, Or P-c, Ma AL-t. Outcomes and perception of cloud-based remote patient monitoring in children receiving automated peritoneal dialysis: a prospective study. Pediatr Nephrol. 2023;38(7):2171–2178.
Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, et al. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):S1–276.
Furie R, Nicholls K, Cheng TT, Houssiau F, Burgos-Vargas R, Chen SL, et al. Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study. Arthritis Rheum. 2014;66(2):379–89.
Liang M, Schur P, Fortin P. Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum. 2006;54(2):421–32.
Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J, et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum. 2012;64(4):1215–26.
Article CAS PubMed Google Scholar
Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol. 2009;20(5):1103–12.
Article CAS PubMed PubMed Central Google Scholar
Group AT. Treatment of lupus nephritis with abatacept: the abatacept and cyclophosphamide combination efficacy and safety study. Arthritis Rheum. 2014;66(11):3096–104.
Furie R, Rovin BH, Houssiau F, Malvar A, Teng YO, Contreras G, et al. Two-year, randomized, controlled trial of belimumab in lupus nephritis. N Engl J Med. 2020;383(12):1117–28.
Article CAS PubMed Google Scholar
Aragon E, Resontoc L, Chan Y, Lau Y, Tan P, Loh H, et al. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis. Lupus. 2016;25(4):399–406.
Article CAS PubMed Google Scholar
Tselios K, Gladman DD, Urowitz MB. How can we define low disease activity in systemic lupus erythematosus? Sem Arthritis Rheum; 2019: Elsevier. p. 1035–40.
Kisaoglu H, Baba O, Kalyoncu M. Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis. Pediatr Nephrol. 2023;38(4):1167–75.
Wahadat MJ, Van Den Berg L, Timmermans D, Van Rijswijk K, van Dijk-Hummelman A, Bakx S, et al. LLDAS is an attainable treat-to-target goal in childhood-onset SLE. Lupus Sci Med. 2021;8(1): e000571.
Article PubMed PubMed Central Google Scholar
Lopes SR, Gormezano N, Gomes RC, Aikawa NE, Pereira RM, Terreri MT, et al. Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups. Lupus. 2017;26(9):996–1001.
Article CAS PubMed Google Scholar
Gibson KL, Gipson DS, Massengill SA, Dooley MA, Primack WA, Ferris MA, et al. Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults. Clin J Am Soc Nephrol. 2009;4(12):1962–7.
Article PubMed PubMed Central Google Scholar
Wenderfer SE, Orjuela A, Bekheirnia MR, Pereira M, Muscal E, Braun MC, et al. Lupus nephritis, autoantibody production and kidney outcomes in males with childhood-onset systemic lupus erythematosus. Pediatric Rep. 2022;14(2):220–32.
Ruggiero B, Vivarelli M, Gianviti A, Benetti E, Peruzzi L, Barbano G, et al. Lupus nephritis in children and adolescents: results of the Italian Collaborative Study. Nephrol Dial Transplant. 2013;28(6):1487–96.
Article CAS PubMed Google Scholar
Lee BS, Cho HY, Kim EJ, Kang HG, Ha IS, Cheong HI, et al. Clinical outcomes of childhood lupus nephritis: a single center’s experience. Pediatr Nephrol. 2007;22(2):222–31.
Chan EY-h, Yap DY-h, Wong WH-s, Wong S-w, Lin KY-k, Hui FY-w, et al. Renal relapse in children and adolescents with childhood-onset lupus nephritis: a 20-year study. rheumatology (Oxford). 2023 Aug 26:kead447. https://doi.org/10.1093/rheumatology/kead447(Online ahead of print).
Groot N, De Graeff
Comments (0)